|Day Low/High||1.38 / 1.40|
|52 Wk Low/High||2.37 / 5.81|
Investors in pSivida Corp saw new options begin trading this week, for the January 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
U.S. and foreign patents for bioerodible Medidur™, new smaller needle Medidur injector and Tethadur™
Results to Form Part of Planned Applications for Marketing Approvals in EU and US
Industry Veteran Brings Over 25 Years of Pharmaceutical and Drug Development Experience
Incremental Risk of Elevated IOP Relative to Control Decreases Through Last Follow-up Visit
Data Presented at 2016 Annual Meeting & Exposition of the Controlled Release Society